Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
2.675
-0.005 (-0.19%)
At close: May 16, 2025, 4:00 PM
2.670
-0.005 (-0.19%)
After-hours: May 16, 2025, 4:18 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $338.18 million as of May 16, 2025. Its market cap has decreased by -59.56% in one year.
Market Cap
338.18M
Enterprise Value
88.46M
1-Year Change
-59.56%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $338.18M, a decrease of -85.04%. That is a compound annual growth rate of -39.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 338.18M | -59.55% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.79B |
| Johnson & Johnson | 358.07B |
| AbbVie | 317.21B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 242.85B |
| Abbott Laboratories | 230.81B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |